Global GammaKnife Market, by Indication (Brain Metastasis, Arteriovenous Malformation(AVM), Trigeminal Neuralgia, Movement Disorders, Cancer and Others), by Anatomy(Neck and Head), by End-user (Hospitals, Clinics and Ambulatory SurgicalCenters), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) was valued at US$ 173.55 million in 2019 and is expected to exhibit a CAGR of 3.2% overthe forecast period (2019-2027).
The rising number of neurologicalsurgeries is expected to drive the growth of the global gamma knife market overthe forecast period. For instance, according to the Healthcare Cost andUtilization Project (HCUP) report, in 2014, 17.2 million hospital visits(ambulatory or inpatient) included invasive and therapeutic surgeries. Overhalf of these visits (9.9 million visits) occurred in ambulatory surgery (AS)settings, and the remaining 7.2 million were inpatient surgeries. Increasingprevalence of brain tumors is expected to boost global gamma knife marketgrowth. For instance, according to the Central Brain Tumor Registry of theUnited States (CBTRUS) 2018, the incidence of all primary malignant and non-malignantbrain tumors, and other CNS tumors was 23.03 cases per 100,000 for 392,982tumors in 2018. According to the same source, an estimated 86,970 new cases ofprimary malignant and non-malignant brain and other CNS tumors are expected tobe diagnosed in the U.S. in 2019. The global gamma knife market size isexpected to witness significant growth during the forecast period, owing toincrease in regulatory approvals for gamma knife products.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/408
For instance, in June 2015,Elekta, received 510(k) clearance from the U.S. Food and Drug Administration(FDA) and CE Marking for Leksell Gamma Knife Icon. Which is the world’s mostprecise and sophisticated system for radiosurgery treatment of certain braintumors, vascular malformations and functional disorders.
Browse 35 Market Data Tables and33 Figures spread through 185 Pages and in-depth TOC on "Global GammaKnife Market, by Indication (Brain Metastasis, Arteriovenous Malformation(AVM), Trigeminal Neuralgia, Movement Disorders, Cancer and Others), by Anatomy(Neck and Head), by End-user (Hospitals, Clinics and Ambulatory SurgicalCenters), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) - Global Forecast to 2027"
In July 2019, University ofMinnesota launches exclusive gamma knife technology for radiation therapy, isused to treat brain tumor patients with the latest generation advancedradiosurgery technology. The radiosurgery works by focusing radiation beamsfrom different angles to a small target.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/gamma-knife-market-408
Key Takeaways of the Global GammaKnife Market:
The global gamma knife market isexpected to exhibit a CAGR of 3.2% over the forecast period (2019–2027) owingto increasing prevalence of brain tumors and number of neurological surgeries
Among indication type, the brainmetastasis segment is expected to account for a major revenue share by 2027.Brain metastasis is a type of cancer that can spread to the brain from anotherlocation in the body and is also considered as secondary brain tumor.
Major players operating in theglobal gamma knife market include Elekta AB, Varian Medical Systems Inc.,Huiheng Medical Inc., Cyber Medical Corporation Limited, Masep Infini GlobalInc., ET Medical Group, Nordion Inc., Hokai and GE Healthcare.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/408
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
